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Abstract
Endometriosis is a chronic neuroinflammatory pain condition affecting ~180 million women worldwide. Surgical removal 
or hormonal suppression of endometriosis lesions only relieves pain symptoms in some women and symptomatic 
relapse following treatment is common. Identifying factors that contribute to pain is key to developing new therapies. 
We collected peritoneal fluid samples and clinical data from a cohort of women receiving diagnostic laparoscopy for 
suspected endometriosis (n = 52). Peritoneal fluid immune cells were analysed by flow cytometry and data compared with 
pain scores determined using the pain domain of the Endometriosis Health Profile Questionnaire (EHP-30) in order to 
investigate the association between peritoneal immune cells and pain symptoms. Pain scores were not different between 
women with or without endometriosis, nor did they differ according to disease stage; consistent with a poor association 
between disease presentation and pain symptoms. However, linear regression and correlation analysis demonstrated 
that peritoneal macrophage abundance correlated with the severity of pelvic pain. CD14high peritoneal macrophages 
negatively correlated with pain scores whereas CD14low peritoneal macrophages were positively correlated, independent 
of diagnostic outcome at laparoscopy. Stratification by pain subtype, rather than endometriosis diagnosis, resulted in 
the most robust correlation between pain and macrophage adundance. Pain score strongly correlated with CD14high 
(P = 0.007) and CD14low (P = 0.008) macrophages in patients with non-menstrual pain and also in patients who reported 
dysmennorhea (CD14high P = 0.021, CD14low P = 0.019) or dysparunia (CD14high P = 0.027, CD14low P = 0.031). These results 
provide new insight into the association between peritoneal macrophages and pelvic pain which may aid the identification 
of future therapeutic targets.
Lay summary
Endometriosis is a common condition where cells similar to those that line the womb are found elsewhere in the body. It 
is associated with inflammation and pain in the pelvis and affects ~180 million women worldwide. Current treatments are 
not effective for all patients and we, therefore, need to understand what causes pain in order to develop new treatments. 
We investigated the types of immune cells present within the pelvis of women undergoing investigation for suspected 
endometriosis. Disease diagnosis and stage (I–IV) was recorded along with pain score determined by questionnaire. 
We characterised the immune cells present and compared them to disease stage and pain score. We found that pelvic 
pain was linked to the abundance of immune cells but, surprisingly, not to disease stage. These findings suggest that 
immune cells are closely associated with pain severity in endometriosis and may be good targets for future endometriosis 
treatments.
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Introduction
Endometriosis is a chronic neuroinflammatory condition 
affecting ~180 million women worldwide and has a 
socioeconomic impact similar to diabetes (Horne & Saunders 
2019). It is defined by the presence of endometrial-like tissue 
outside the uterus (‘lesions’), commonly within the pelvic 
cavity. The most common symptoms of endometriosis 
are chronic pelvic pain, dyspareunia, dysmenorrhoea and 
non-menstrual pain (Horne & Saunders 2019, Zondervan 
et al. 2020). While the exact aetiology of endometriosis is 
unknown, changes in inflammatory processes are thought 
to contribute to the pathogenesis of the disease.
The definitive method to diagnose endometriosis 
is by visualisation at the time of surgery (laparoscopy). 
Endometriosis is further staged according to the revised 
scoring system of the American Society for Reproductive 
Medicine (rASRM) to determine the endometriosis stage 
based on macroscopic features of the disease including 
location/appearance of lesions and extent of disease 
(ranging from I to IV) (1997). Although this staging is 
commonly used to define disease burden, comparisons 
between patient-reported severity of pain symptoms 
and rASRM stage consistently report a poor correlation 
(Vercellini et  al. 2007). For example, a multivariate 
analysis of over 1000 patients assessing the correlation 
between endometriosis stage, lesion type and pain severity 
demonstrated that deep endometriosis is associated with 
pain symptoms characteristic of anatomical location 
(dyspareunia) but evidence for an association of other 
pain subtypes (dysmenorrhea, non-menstrual pain) 
with disease severity/location was marginal (Vercellini 
et  al. 2007). Dysmenorrhea is reported to be more 
frequent and to result in higher pain scores in women 
with endometriosis but this is also independent of 
lesion location (Fauconnier & Chapron 2005). Notably, 
pelvic pain symptoms are common, with up to 90% of 
women reporting having experienced dysmenorrhea, 
42% dyspareunia and 39% acyclic (non-menstrual) pain 
(Jamieson & Steege 1996) at some time in their lives. 
The relationship between pain symptoms and diagnosed 
endometriosis is further complicated by the identification 
of lesions in asymptomatic women (Fauconnier & 
Chapron 2005). These data demonstrate that identifying 
potential pathophysiological mechanisms responsible for 
pain, beyond those associated with endometriosis lesions, 
remains important as a step towards improved patient-
focused therapies.
Peritoneal macrophages are the most abundant 
immune cell in the peritoneal cavity (Kubicka et  al. 
1996) with defined roles in clearance of apoptotic 
cells and immune surveillance. Analysis of peritoneal 
fluid from women with endometriosis suggests that 
the inflammatory microenvironment is altered in the 
peritoneal cavity of women with disease. Notably, 
increased concentrations of macrophage growth factors 
and chemokines such as colony-stimulating factor 1 
(CSF1) and monocyte chemoattractant protein 1 (CCL2) 
are detected in peritoneal fluid from women with 
endometriosis (Arici et al. 1997, Budrys et al. 2012, Beste 
et al. 2014) and this is associated with increased numbers 
of peritoneal macrophages compared to women without 
disease (Hill et al. 1988, Beste et al. 2014, Gogacz et al. 
2017). Furthermore, peritoneal macrophage function 
appears to be dysregulated in endometriosis patients 
and this is characterised by increased secretion of pro-
inflammatory cytokines and reduced phagocytic capacity 
(Chuang et  al. 2009, Punnonen et  al. 1996, Richter 
et  al. 2005, Beste et  al. 2014). Peritoneal macrophage 
dysfunction is thought to contribute to the establishment 
of lesions in women with endometriosis, although the 
mechanistic evidence for this is largely based on studies in 
mouse models. These studies demonstrate that peritoneal 
macrophages are increased in experimentally induced 
endometriosis and are required for the vascularisation 
and growth of endometriosis lesions (Bacci et  al. 2009, 
Capobianco et al. 2011).
Macrophage dysfunction may also affect pain 
symptoms via secretion of neurotrophic factors that 
promote nerve growth (Kajitani et  al. 2013). Notably, 
CD68-positive macrophages are reported to co-localise 
with nerve fibres within peritoneal endometriotic 
lesions and it has been speculated that they can promote 
endometriosis pain symptoms in women (Tran et  al. 
2009). In a mouse model of endometriosis, peritoneal 
macrophages appeared to promote endometriosis-
associated hyperalgesia, putatively via secretion of 
macrophage-derived insulin-like growth factor 1 (Forster 
et al. 2019).
Macrophages are highly diverse and we need a 
better understanding of the different subpopulations 
present in endometriosis in order to determine if they 
have distinct functional roles. Studies in other contexts 
have reported there is heterogeneity within human 
peritoneal macrophage populations and at least two 
subsets can be identified by assessing the expression of 
canonical markers, such as CD14, CD16 and HLA-DR 
(Ruiz-Alcaraz et al. 2016, 2018) or complement receptor 
of the immunoglobulin superfamily (CRIg) (Irvine et al. 
2016). Notably, these peritoneal macrophage subsets 
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appear to be altered in disease states, such as liver 
cirrhosis (Irvine et al. 2016).
The objective of this study was to phenotype and 
quantify peritoneal macrophage subpopulations in 
women undergoing diagnostic laparoscopy for suspected 
endometriosis and to determine whether this was 




Written informed consent was obtained from all study 
participants prior to surgery; ethical approval was granted 
by the Lothian Research Ethics Committee (LREC 11/
AL/0376). Methods were carried out in accordance 
with NHS Lothian Tissue Governance guidelines and 
EPHect guidelines (https://endometriosisfoundation.org/
ephect/).
Clinical samples and patient data
Eligible participants were women with chronic pelvic 
pain (aged 18–50 years) of >3 months duration who 
were undergoing diagnostic laparoscopy for suspected 
endometriosis in NHS Lothian, UK. Pelvic pain was 
defined as pain located within the true pelvis (between 
and below the anterior iliac crests). Screening commenced 
on 23/10/2014 and last participant recruited on 
03/05/2016. Of the 202 women who were approached 
for participation, 121 consented to take part. Peritoneal 
fluid was recovered from 74 women during surgery, of 
which 52 had sufficient volume for downstream analysis. 
22 participants were excluded from the study due to 
insufficient peritoneal fluid volume. Pain scores were 
determined using the pain domain of the Endometriosis 
Health Profile Questionnaire (EHP-30) (a validated 
endometriosis-specific pain questionnaire completed 
pre-operatively (20)). Age, BMI, menstrual cycle stage 
and hormone status were obtained and recorded along 
with other key clinical data (Supplementary Tables 1 
and 2, see section on supplementary materials given at 
the end of this article). For 29 women who were not on 
hormones and had regular menstrual cycles, the diagnosis 
of endometriosis was confirmed macroscopically at 
laparoscopy in 19 women, whereas no evidence of 
endometriosis was found in ten women (‘no endo’). 
Women with endometriosis diagnosis were subsequently 
classified according to the revised scoring system of the 
American Society for Reproductive Medicine (rASRM) 
as stage I (n = 10), II (n = 4) and III/IV (n = 5). For some 
analyses, the remaining 25 women who were receiving 
hormone treatment were included. In women who met 
this criterion, diagnosis of endometriosis was confirmed 
in 14 women, while 11 were classified as ‘no endo’ (no 
obvious pelvic pathology at laparoscopy).
Flow cytometry
Immune cells recovered from peritoneal fluid were 
analysed by flow cytometry using standard methods 
(McKinnon 2018). Briefly, cells were washed and subjected 
to red cell lysis before being counted and resuspended in 
FACS buffer at a concentration of 0.5–1 × 106 cells/100 
µL. Antibodies were used at manufacturer’s recommended 
concentration (Supplementary Table 3). Cells were gated 
to select immune cells (live, CD45+) and further sub-gated 
to select myeloid cells (CD11b+) and exclude T, B and NK 
cells (CD3−, CD19−, CD56−). Gating of subpopulations 
was performed based on fluorescence minus one (FMO) 
and population distribution (CD14). This population 
gating was applied to all samples. Samples were assessed 
using a Becton Dickinson FACS Aria II. Data were analysed 
using FlowJo™ Software.
Statistical analysis
Statistical analysis was performed using Graphpad prism. 
T test was used to test the difference in the means of 
two groups. Two-way ANOVA was used to determine the 
significance between treatments in grouped data. Non-
parametric testing was utilised where sample sizes were 
insufficient to confirm normality of data distribution; 
Kruskal–Wallis test was used to assess differences between 
multiple groups or Mann–Whitney test to assess variance 
between two groups. Pearson correlation was used to 
quantify the degree to which two variables (macrophages 
abundance and pain score) were related. Criterion 
for significance was P < 0.05. All data are presented as 
mean ± s.e.m.
Results
Pelvic pain does not correlate with endometriosis 
diagnosis or disease stage
Baseline characteristics of the patient cohort were assessed 
to identify potential factors which may influence pelvic 
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pain in women. Pain scores were determined using the 
pain domain of the EHP-30 questionnaire (Jones et  al. 
2001). For women who were not on hormones; Age, BMI, 
and pain scores did not differ between those women 
categorised as ‘no endo’ or those with surgically diagnosed 
endometriosis (Fig. 1A and Supplementary Table 1). 
There was no statistically significant difference in pain 
score between endometriosis rASRM stages I, II or III/IV, 
although pain scores were highly variable (Fig. 1B). Oral 
contraceptives and treatments which suppress hormone 
production are reported to decrease endometriosis-
associated pain in some women (Taylor et  al. 2017, 
Crosignani et al. 2006). In this study, pain scores in women 
receiving hormonal treatment (H) were not different from 
those women who were not on hormones (NH) and this 
was true in women with (Fig. 1C) and without (Fig. 1D) a 
confirmed surgical diagnosis of endometriosis.
Two populations of peritoneal macrophages are 
present in the peritoneal fluid of women with 
suspected endometriosis which are not altered by 
hormone status
Cells were recovered from peritoneal fluid and analysed 
by flow cytometry. Cells were gated to select immune cells 
and further sub-gated to select myeloid cells and exclude 
T, B and NK cells (Fig. 2A and B). Two populations of 
peritoneal macrophages (PMφ) were identified which were 
HLA-DR-positive and had either high or low-intensity 
expression of CD14 (Fig. 2C).
In women with regular menstrual cycles, the phase 
of the menstrual cycle (categorised as proliferative 
or secretory), had no significant impact on the 
abundance of CD14high or CD14low PMφ populations 
(Fig. 2D). Although hormone treatment did not alter the 
abundance of any of these immune cell populations (Fig. 
2E and Supplementary Fig. 1), samples from patients on 
hormones were excluded from the subsequent analysis to 
avoid any confounding effects of this variable on other 
disease parameters.
Peritoneal macrophages are not altered by infertility 
or heavy menstrual bleeding
We next assessed whether the co-morbidities infertility 
or heavy menstrual bleeding (HMB), recorded as part of 
patient cohort data collection, could affect the abundance 
of PMφ subpopulations. Infertility did not alter the 
abundance of CD14high or CD14low macrophages in 
women with endometriosis (Fig. 2F). PMφ populations 
were not altered by the presence of HMB (Fig. 2G).
CD14high peritoneal macrophages are increased in 
women with endometriosis
PMφ were assessed in all women within the cohort who 
had regular cycles and were not receiving hormone 
treatment and comparisons made between ‘No endo’ 
and those with endometriosis (pooled ‘rASRM I–IV’). 
CD14high PMφ were significantly higher in women with 
endometriosis (rASRM I–IV) compared to women without 
disease (Fig. 3A, P < 0.05). No significant difference was 
found for CD14low PMφ, although the average appeared 
lower for women with endometriosis (Fig. 3B). To 
assess the relationship between the two populations we 
calculated the ratio of CD14high to CD14low macrophages. 
CD14high PMφ were the predominant population in 
the peritoneal cavity and this difference was more 
pronounced in women with endometriosis (Fig. 3C) and 
with increasing rASRM stage (Fig. 3D). Analysis according 
to rASRM stage (Fig. 3C) identified a significant difference 
between subpopulations of CD14high and CD14low PMφ in 
women classified as rASRM stage I (P < 0.01), II (P < 0.0001) 
or III/IV (P < 0.001). No significant difference was found 
between CD14high and CD14low PMφ in women without 
endometriosis.
Figure 1 Pain score does not differ by endometriosis diagnosis, stage of 
disease or hormone treatment. (A) Presence/absence of endometriosis 
did not affect the pain score (pain domain of EHP30) and (B) did not differ 
according to rASRM stage. Hormone treatment did affect pain score in 
women without (C) or with endometriosis diagnosis (D).
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Peritoneal macrophages correlate with pelvic pain 
scores in women with endometriosis and are 
influenced by pain subtype
The abundance of either CD14high or CD14low PMφ was 
compared to pain scores in women with endometriosis who 
were not on hormones and Pearson correlation calculated. 
In women who were diagnosed with endometriosis 
(rASRM I–IV), CD14high PMφ did not significantly correlate 
with pain score (Fig. 4, All, P = 0.057), although a trend 
for negative correlation was evident. However, CD14low 
PMφ showed a moderate positive relationship with the 
pain score that was borderline significant (Fig. 4, All, 
P = 0.047). No correlation was observed in women without 
endometriosis, irrespective of hormone status, but these 
subgroups had the fewest patients (Supplementary Fig. 2).
To account for different pain subtypes within women 
with endometriosis, patients were stratified based on 
reported presence of pain subtypes; dysmenorrhea 
(DM), dyspareunia (DP) and non-menstrual pain 
(NMP). Dysmenorrhea was present in the majority of 
endometriosis patients (89.5%, Supplementary Table 4) 
and comparisons were therefore similar to those that 
accounted for all endometriosis patients; CD14high PMφ 
did not significantly correlate with pain score (Fig. 4, DM, 
P = 0.057) but CD14low PMφ showed a significant positive 
relationship with pain score (Fig. 4, DM, P =0.049).
Dyspareunia was less common than dysmenorrhea in 
endometriosis patients (73.7%, Supplementary Table 4). 
CD14high PMφ had a significant negative correlation with 
pain score (Fig. 4, DP, P = 0.044) and CD14low PMφ had a 
significant positive correlation with pain score (Fig. 4, DP, 
P = 0.031).
Non-menstrual pain (NMP) was commonly reported 
in endometriosis patients (84.2%, Supplementary Table 
4). CD14high PMφ had a significant negative correlation 
with pain score (Fig. 4, NMP, P = 0.015) and CD14low PMφ 
had a significant positive correlation with pain score 
(Fig. 4, NMP, P = 0.015).
Based on calculated correlation coefficient values 
(r), the strongest relationship between PMφ and pain 
scores was in women with endometriosis who reported 
experiencing pain outwith menses (non-menstrual pain; 
NMP). Notably, multiple pain subtypes were present in 
many patients and stratification was therefore based on 
the presence of a given subtype. To account for potential 
interactions between pain subtypes, correlations were 
also calculated on the basis of whether patients reported 
both DM and DP, DM and NMP, DP and NMP or all three 
Figure 2 Analysis of peritoneal fluid immune cells 
from women with diagnosed endometriosis 
reveals two populations of peritoneal 
macrophages that are not altered by hormones or 
other reproductive health disorders. 
Representative flow cytometry plots from pelvic 
peritoneal fluid (PF) immune cells. Cells were 
gated to select; (A) Live, CD45+ (all immune cells) 
and (B) CD11b+ (myeloid cells), CD3−CD19−CD56− 
(‘DUMP’; T, B and NK cells). (C) Two peritoneal 
macrophage (PMφ) subpopulations were 
identified that were HLA-DR+ and CD14+ (High vs 
low). (D) Phase of the menstrual cycle (Pro: 
proliferative; Sec: secretory) did not affect the 
abundance of CD14high (t test, P = 0.5035) or 
CD14low cells (Mann–Whitney test, P = 0.7664) thus 
samples were thereafter not stratified on this 
basis. (E) The abundance of CD14high (Mann–
Whitney test, P = 0.3723) or CD14low cells (Mann–
Whitney test, P = 0.3345) did not differ if women 
were not on hormones (NH) or on a hormonal 
treatment (H). (F) The abundance of CD14high or 
CD14low peritoneal macrophages (PMφ) did not 
differ between women reporting infertility (True) 
and those who did not (False). (G) The abundance 
of CD14high or CD14low PMφ in women with 
endometriosis did not differ between women 
reporting HMB (True) and those who did not 
(False).
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subtypes but this did not affect the correlations reported 
by individual pain subtypes (Supplementary Table 4).
Peritoneal macrophages correlate with severity of 
pelvic pain in women irrespective of 
endometriosis diagnosis
To extend the data on women with endometriosis, the 
abundance of either CD14high or CD14low PMφ was also 
compared to pain scores using data from all women in 
our cohort who were not on hormones (No endo and 
rASRM I–IV combined) and Pearson correlation calculated 
(Fig. 5). A significant correlation was found for all patients 
for both CD14high (Fig. 5, All, P = 0.031), and CD14low PMφ 
(Fig. 5, All, P = 0.032) with pain score. This was also true 
when data were stratified by pain subtype.
Dysmenorrhea was present in most patients (80%, 
Supplementary Table 4). In women with dysmenorrhea, 
CD14high PMφ negatively correlated with pain score (Fig. 5, 
DM, P = 0.021) and CD14low PMφ showed a significant 
Figure 3 CD14high peritoneal macrophages are increased in women with 
endometriosis. (A) Frequency of CD14high peritoneal macrophages (PMφ) 
was greater in women with endometriosis (rASRM stages I–IV, n = 19, t 
test, P < 0.05) than those without endometriosis (‘No endo’; n = 10). (B) 
Frequency of CD14low PMφ was not significantly different in women with 
endometriosis compared to those without disease. (C) The ratio of 
CD14high to CD14low PMφ was greater in women with endometriosis 
(rASRM I–IV) than those without endometriosis (no endo). (D) The ratio of 
CD14high to CD14low PMφ was greater in women from each rASRM stage 
than those without endometriosis (no endo). (E) CD14high PMφ were 
significantly higher than CD14low PMφ in women with endometriosis 
stratified according to rASRM I (n = 10, P < 0.01), rASRM II (n = 4, P > 
0.0001) and rASRM III/IV (n = 5, P > 0.001) but not in women without 
endometriosis (n = 9; two-way ANOVA). *P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001.
Figure 4 Peritoneal macrophages correlate with the severity of pelvic pain 
in women with endometriosis and are influenced by pain subtype. 
Frequency of CD14high PMφ did not significantly correlate with pain scores 
(n = 20, P = 0.057) but CD14low PMφ showed a significant positive 
correlation with pain score in endometriosis patients (n = 20, P = 0.047). 
Patients were stratified based on reported presence of pain subtypes; 
dysmenorrhea (DM), dyspareunia (DP) and non-menstrual pain (NMP). 
Endometriosis patients who reported dysmenorrhea showed moderate 
positive correlation between CD14low PMφ and pain score (n = 19, P = 
0.049) but no significant correlation between CD14high PMφ and pain 
score. Endometriosis patients who reported dyspareunia showed a 
significant negative correlation between CD14high PMφ and pain score (n = 
13, P = 0.0441) and a significant positive correlation between CD14low PMφ 
and pain score (n = 13, P = 0.0301). Endometriosis patients who reported 
non-menstrual pain showed a significant negative correlation between 
CD14high PMφ and pain score (n = 16, P = 0.0147) and a significant positive 
correlation between CD14low PMφ and pain score (n = 16, P = 0.0146). P 
value, correlation coefficient (r) and goodness of fit (R2) calculated by 
Pearson correlation. Line of best fit calculated by simple linear regression 
(black line) with 95% CIs (dashed line). NH, not on hormones. Attribution 
of pain subtype was not exclusive as multiple subtypes were reported in 
some patients.
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positive relationship with pain score (Fig. 5, DM, P = 0.019). 
Dyspareunia was less common than dysmenorrhea (70%, 
Supplementary Table 4). CD14high PMφ had a significant 
negative correlation with pain score (Fig. 5, DP, P = 0.027) 
and CD14low PMφ had a significant positive correlation 
with pain score (Fig. 5, DP, P = 0.031). Non-menstrual pain 
(NMP) was commonly reported (76.7%, Supplementary 
Table 4). CD14high PMφ had a strong significant negative 
correlation with pain score (Fig. 5, NMP, P = 0.007) and 
CD14low PMφ had a significant positive correlation with 
pain score (Fig. 5, NMP, P = 0.008). Similar to the analysis 
of data from the subgroup of women who were diagnosed 
with endometriosis, when all patients were considered 
the strongest relationship between PMφ and pain scores 
was in women who reported experiencing non-menstrual 
pain (CD14high r = −0.56; CD14low, r = 0.55).
Discussion
Peritoneal macrophages are believed to play a fundamental 
role in the pathophysiology of endometriosis (Bacci et al. 
2009, Yuan et al. 2016, Horne & Saunders 2019, Zondervan 
et al. 2020) but to date, information regarding different 
phenotypes of macrophage and how they relate to pain 
symptoms in women has been limited. In this study, we 
performed multi-parameter flow cytometry analysis of 
peritoneal fluid immune cells from women undergoing a 
diagnostic laparoscopy for suspected endometriosis. We 
believe our data are the first to demonstrate that a CD14high 
PMφ subset are increased in women with laparoscopically 
diagnosed endometriosis and that the abundance of 
both CD14high and CD14low PMφ populations correlate 
with pain symptoms independent of the endometriosis 
diagnosis.
In a previous study, researchers reported an increase 
in the abundance of macrophages in the peritoneal fluid 
of 37 women with endometriosis based on the expression 
of the macrophage marker CD68 (Beste et al. 2014) which 
is consistent with the subset specific increase in CD14high 
detected in the current study. Based on relative abundance 
and comparative transcriptional profiling in other studies 
(Irvine et al. 2016), we believe CD14high and CD14low to be 
broadly equivalent to large (LpM) or small (SpM) peritoneal 
macrophage populations described in mice (Cassado et al. 
2015). In response to peritoneal cavity inflammation in 
mice, LpM decrease and this is associated with infiltration 
of monocytes that replenish the LpM pool. Notably, it is 
not possible to distinguish between ‘resident’ PMφ and 
infiltrating monocytes in women as they both express 
CD14. Thus, the increase in CD14high cells we detected in 
women with endometriosis may in part be accounted for 
by monocyte infiltration. This may also be reflected by the 
increase in the proportion of CD14high relative to CD14low 
we detected with rASRM stages I, II and III/IV which may 
be associated with increased peritoneal inflammation in 
response to disease burden. Future studies will need to 
Figure 5 Peritoneal macrophages correlate with the severity of pelvic pain 
in women with suspected endometriosis irrespective of diagnosis. 
Frequency of CD14high PMφ significantly negatively correlated with pain 
score (n = 28, P = 0.031) and CD14low PMφ showed a significant positive 
correlation with pain score (n = 28, P = 0.032) in all patients irrespective of 
the endometriosis diagnosis. Patients were stratified based on reported 
presence of pain subtypes; dysmenorrhea (DM), dyspareunia (DP) and 
non-menstrual pain (NMP). Patients who reported dysmenorrhea showed 
a significant negative correlation between CD14high PMφ and pain score 
(n = 26, P = 0.0212) and a significant positive correlation between CD14low 
PMφ and pain score (n = 26, P = 0.01865). Patients who reported 
dyspareunia showed a significant negative correlation between CD14high 
PMφ and pain score (n = 19, P = 0.0270) and a significant positive 
correlation between CD14low PMφ and pain score (n = 19, P = 0.0306). 
Patients who reported pain non-menstrual pain showed a significant 
negative correlation between CD14high PMφ and pain score (n = 22, P = 
0.0074) and a significant positive correlation between CD14low PMφ and 
pain score (n = 22, P = 0.0083). P value, correlation coefficient (r) and 
goodness of fit (R2) calculated by Pearson correlation. Line of best fit 
calculated by simple linear regression (black line) with 95% confidence 
intervals (dashed line). NH, not on hormones. Attribution of pain subtype 
was not exclusive as multiple subtypes were reported in some patients.
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profile paired monocyte and PMφ samples from women 
with endometriosis in order to distinguish their respective 
contribution to the altered peritoneal microenvironment 
that exists in women with endometriosis.
We assessed pain scores in 52 women who were 
scheduled to have a diagnostic laparoscopy for suspected 
endometriosis. Pelvic pain symptoms were recorded 
using the pain dimension of the EHP-30 questionnaire, 
an extensively validated endometriosis-specific health-
related quality of life measurement (Jones et  al. 2004, 
Bourdel et  al. 2019). We found that pain scores in our 
cohort of women with endometriosis (mean and s.e.m., 
45.5 ± 5.54) were comparable to previous data generated 
using the EHP-30 questionnaire in larger cohorts of 
women from the UK (mean pain score 43.3, n = 594 
women), USA (mean pain score 49.3, n = 225 women) and 
Australia (mean pain score 40.7, n = 189 women) (Jones 
et al. 2006, Jenkinson et al. 2008, Khong et al. 2010) so 
we believe they are representative of this patient group. 
These previous studies focused on pain scores in women 
with surgically diagnosed endometriosis but in the current 
study, we also analysed pain scores in women who did 
not receive a diagnosis of endometriosis at laparoscopy. 
Interestingly, mean pain score in the ‘no endo’ group was 
higher (mean and s.e.m., 57.3 ± 4.78) than women with 
endometriosis but variation within groups meant this was 
not statistically significant when compared to pain scores 
in women with endometriosis. Pain scores were also not 
significantly different between patients graded as rASRM 
stage I (47.3), II (38.3) or III/IV (47.8). Thus, in the current 
patient cohort, neither a diagnosis of endometriosis nor 
rASRM stage affected pain scores. Taken together, these 
data confirm previous findings that pain symptoms do 
not correlate well with disease presentation (Vercellini 
et al. 2007).
We profiled peritoneal cavity immune cells to 
determine if changes in the inflammatory environment 
could predict the severity of pain symptoms. Broadly, 
we found a negative correlation between CD14high PMφ 
and pelvic pain and a positive correlation between 
CD14low PMφ and pelvic pain. These correlations were 
significant in patients with endometriosis but also when 
the whole patient cohort was evaluated independently 
of the endometriosis diagnosis. The correlation between 
the abundance of peritoneal macrophage subsets and 
pain score was more pronounced when patients were 
stratified by pain subtype. Patients who reported non-
menstrual pain showed a marked significant correlation 
between peritoneal macrophages and pain score and these 
patients also showed the strongest correlation coefficient. 
This suggests a potential disconnect between pain and 
menstrual dysfunction, reinforcing the possibility that 
inflammatory changes in the peritoneal environment may 
be a greater driver of pain symptoms in some patients. 
Thus, although some patients may have no ‘active’ or 
visible endometriosis at the time of laparoscopy they 
may exhibit detectable changes in macrophages which 
correlate to pelvic pain.
A previous study reported a correlation between 
concentrations of IL6 in peritoneal fluid and pelvic pain 
symptoms in women with endometriosis (Velasco et  al. 
2010). Notably, PMφ are reported to be the principle 
source of IL-6 and this cytokine is increased in peritoneal 
fluid in women with endometriosis (Wu et al. 1999). Pain 
symptoms may therefore be affected by secretion of pro-
inflammatory cytokines from PMφ in response to ‘active’ 
disease or as a legacy of previous inflammation from 
‘historic’ disease. Thus, further profiling of peritoneal 
macrophages to account for both their phenotype and 
function could provide new insights into the relationship 
between endometriosis and pelvic pain symptoms. 
Notably, accounting for pain subtype as well as the 
severity of pelvic pain symptoms will provide the greatest 
resolution for identifying specific mediators with the 
potential to promote inflammatory pain.
Current treatment approaches for endometriosis 
focus on either surgical removal of disease or hormonal 
suppression of lesion growth but this does not improve 
pain symptoms in all women (Taylor et al. 2017, Saraswat 
et  al. 2018, Pokrzywinski et  al. 2020). Furthermore, 
symptomatic relapse or further surgery occurs in 24–72% 
of women within 7 years of the initial surgery (reviewed 
in Guo & Martin 2019). We have previously shown that 
sham surgery in the peritoneal cavity of mice dramatically 
alters the composition of peritoneal macrophages by 
promoting increased replenishment by blood monocytes 
(Bain et al. 2020). Notably, this was detectable for up to 8 
weeks post-surgery consistent with surgical intervention 
having a lasting effect on the peritoneal inflammatory 
environment in mice (Bain et al. 2020). In the context of 
the current results, we, therefore, speculate that surgical 
treatment itself could alter the peritoneal environment 
which raises the possibility that surgery could exacerbate 
pain symptoms in some patients. This may explain some 
of the contradictory findings assessing the impact of 
surgery on pain symptoms in women with superficial 
peritoneal endometriosis (Horne et al. 2019). The results 
of the current study suggest that assessing peritoneal 
macrophages could provide useful insights into the 
impact of surgical treatment as well as the inflammatory 
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profile of patients with recurrent pain. Our new data also 
highlights the possibility that pain responses to non-
surgical treatments may be influenced by peritoneal 
macrophage function. For example, GnRH agonists 
which reduce pelvic pain in women with endometriosis 
(Brown et al. 2010) can increase PMφ cytotoxicity (Braun 
et  al. 1992) and reduce peritoneal fluid concentrations 
of the pain-correlated cytokine IL6 (Kuroda et al. 2010). 
GnRH modulators do not improve pain symptoms in 
all women (Taylor et  al. 2017, Pokrzywinski et  al. 2020) 
which could be accounted for by baseline differences 
in peritoneal macrophage phenotype or function. We, 
therefore, propose that profiling PMφ may have future 
utility for predicting response to surgical treatment and as 
a means for assessing the impact of medical treatments on 
inflammatory processes that drive pain symptoms.
Conclusions
The novel findings in this study provide new evidence for 
a link between the abundance of peritoneal macrophage 
subpopulations and the experience of pelvic pain 
symptoms in women. Collectively, our data suggest that 
the inflammatory profile of the peritoneal environment 
may be a better predictor of pain symptoms than the 
presence/volume of endometriosis lesions identified 
during laparoscopy. Reframing this perspective opens 
a path to future targeted therapies that aim to alter 
peritoneal macrophage function and reduce pelvic pain 
symptoms in women.
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